Anti-CGRP Monoclonal Antibodies for the Treatment of Migraine with Aura: a prospective observational cohort study

被引：0
|
作者：
Braca, S. [1 ]
Russo, C. [1 ]
Miele, A. [1 ]
Stornaiuolo, A. [1 ]
Sansone, M. [1 ]
De Simone, R. [1 ]
机构：
[1] Univ Naples Federico II, Dept Neurosci Reprod Sci & Dent, Naples, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-083
引用
收藏
页码：376 / 376
页数：1
相关论文
共 50 条
  • [1] Effects of multiple treatment cycles with anti-CGRP monoclonal antibodies on migraine course: a multicenter, prospective, observational study
    Aurilia, Cinzia
    Egeo, Gabriella
    Proietti, Stefania
    Torelli, Paola
    Cevoli, Sabina
    D'Onofrio, Florindo
    Carnevale, Antonio
    Orlando, Bianca
    Fiorentini, Giulia
    Bonassi, Stefano
    Barbanti, Piero
    CEPHALALGIA, 2023, 43 (1supp) : 249 - 249
  • [2] Anti-CGRP and Anti-CGRP Receptor Monoclonal Antibodies for Migraine Prophylaxis: Retrospective Observational Study on 209 Patients
    Schweiger, Vittorio
    Bellamoli, Paola
    Taus, Francesco
    Gottin, Leonardo
    Martini, Alvise
    Nizzero, Marta
    Bonora, Eleonora
    Del Balzo, Giovanna
    Donadello, Katia
    Secchettin, Erica
    Finco, Gabriele
    De Santis, Daniele
    Polati, Enrico
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (04)
  • [3] Effectiveness of anti-CGRP monoclonal antibodies in the preventive treatment of migraine: A prospective study of 63 patients
    Castrillo, Ana
    Mendoza, Amelia
    Caballero, Lorena
    Cerdan, Debora
    Rodriguez, Maria Fernanda
    Guerrero, Pilar
    Tabernero, Cesar
    Ferrero, Marta
    Benito, Ines
    Marin, Laura
    Duarte, Jacinto
    MEDICINA CLINICA, 2023, 160 (08): : 341 - 346
  • [4] The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine
    Fred Cohen
    Hsiangkuo Yuan
    E. M. G. DePoy
    Stephen D. Silberstein
    Neurotherapeutics, 2022, 19 : 922 - 930
  • [5] Synergism of Anti-CGRP Monoclonal Antibodies and OnabotulinumtoxinA in the Treatment of Migraine
    Hennessy, Elise
    Salim, Amira
    Biswas, Sudipa
    Suneja, Aarushi
    Mays, Maryann
    Ahmed, Zubair
    Mata, Ignacio
    NEUROLOGY, 2023, 100 (17)
  • [6] The Arrival of Anti-CGRP Monoclonal Antibodies in Migraine
    Cohen, Fred
    Yuan, Hsiangkuo
    DePoy, E. M. G.
    Silberstein, Stephen D.
    NEUROTHERAPEUTICS, 2022, 19 (03) : 922 - 930
  • [7] Synergism of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in the treatment of migraine
    Hennessy, E.
    Salim, A.
    Biswas, S.
    Sonneborn, C.
    Hogue, O.
    Suneja, A.
    Mays, M.
    Ahmed, Z.
    Mata, I
    HEADACHE, 2023, 63 : 170 - 171
  • [8] Anti-CGRP monoclonal antibodies in migraine: current perspectives
    Giamberardino, Maria Adele
    Affaitati, Giannapia
    Curto, Martina
    Negro, Andrea
    Costantini, Raffaele
    Martelletti, Paolo
    INTERNAL AND EMERGENCY MEDICINE, 2016, 11 (08) : 1045 - 1057
  • [9] Safety concerns of treatment with anti-CGRP monoclonal antibodies in patients with migraine
    van der Arend, Britt W. H.
    van Veelen, Nancy
    de Ruijter, Joelle E. T.
    Olsen, Michael H.
    van den Brink, Antoinette Maassen
    Terwindt, Gisela M.
    CEPHALALGIA, 2023, 43 (1supp) : 233 - 233
  • [10] Ultra-late response (> 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study
    Piero Barbanti
    Cinzia Aurilia
    Gabriella Egeo
    Stefania Proietti
    Florindo D’Onofrio
    Paola Torelli
    Marco Aguggia
    Davide Bertuzzo
    Cinzia Finocchi
    Michele Trimboli
    Sabina Cevoli
    Giulia Fiorentini
    Bianca Orlando
    Maurizio Zucco
    Laura Di Clemente
    Ilaria Cetta
    Bruno Colombo
    Monica Laura Bandettini di Poggio
    Valentina Favoni
    Licia Grazzi
    Antonio Salerno
    Antonio Carnevale
    Micaela Robotti
    Fabio Frediani
    Claudia Altamura
    Massimo Filippi
    Fabrizio Vernieri
    Stefano Bonassi
    Journal of Neurology, 2024, 271 : 2434 - 2443
12345